MADRID, June 7 (Reuters) - Spain's Grifols has agreed to buy U.S.-based Talecris Biotherapeutics , which makes plasma-based protein medicines, for $3.4 billion in a bold move to expand its business in ...
Add Yahoo as a preferred source to see more of our stories on Google. Health Canada says the Grifols plasma donation centre in Regina violated policy requiring at least a two-day gap between a person ...
Spanish drugmaker Grifols SA paid a higher price to buy blood plasma from an entity linked to its controlling family than from third-party suppliers, according to a regulator’s findings submitted in a ...
The Globe and Mail: Grifols donors not informed their plasma is used for drugs sold overseas, MPs hear
Donors giving blood plasma at Grifols’ paid collection centres are not informed that some medicines made from their donations will be sold for profit overseas, according to testimony from a Canadian ...
Grifols donors not informed their plasma is used for drugs sold overseas, MPs hear
MarketWatch: Health Coalition demands disclosures & end to Grifols' for-profit blood plasma contract following reports of deaths, harm, non-compliance
Health Coalition demands disclosures & end to Grifols' for-profit blood plasma contract following reports of deaths, harm, non-compliance
Grifols is a global, Spanish-based biotech company that is a favorite for many European investors, despite the fact that the company does not pay a dividend. It's one of the more well-known Spanish ...
The Globe and Mail: Government probes into the deaths of two plasma donors found no link to Grifols’ donation process
Federal and provincial health probes into the deaths of two people following plasma donations at for-profit Grifols collection centres in Winnipeg found no link between the donation process and the ...